Cargando…
Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity
The cystic fibrosis transmembrane conductance regulator (CFTR) attenuates sphingosine-1-phosphate (S1P) signaling in resistance arteries and has emerged as a prominent regulator of myogenic vasoconstriction. This investigation demonstrates that S1P inhibits CFTR activity via adenosine monophosphate-...
Autores principales: | Malik, Firhan A., Meissner, Anja, Semenkov, Illya, Molinski, Steven, Pasyk, Stan, Ahmadi, Saumel, Bui, Hai H., Bear, Christine E., Lidington, Darcy, Bolz, Steffen-Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469317/ https://www.ncbi.nlm.nih.gov/pubmed/26079370 http://dx.doi.org/10.1371/journal.pone.0130313 |
Ejemplares similares
-
Functional Rescue of F508del-CFTR Using Small Molecule Correctors
por: Molinski, Steven, et al.
Publicado: (2012) -
Synergy of cAMP and calcium signaling pathways in CFTR regulation
por: Bozoky, Zoltan, et al.
Publicado: (2017) -
A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 Patients
por: Lidington, Darcy, et al.
Publicado: (2020) -
Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries
por: Hui, Sonya, et al.
Publicado: (2015) -
Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface
por: Chin, Stephanie, et al.
Publicado: (2017)